Search Results

 

You need to login or register to view this content

All our reports and results are available free of charge personal use, and/or non-commercial use, however, you must first register with us to view our data.

View full Terms and Conditions



Log In

Respondent CDP 2009: AstraZeneca

General introduction


Risk and Opportunities
1 Regulatory Risks (CDP6 1(a)(i))
1 1 company exposed regulatory risks related climate change
We consider our company to be exposed to regulatory risks. 
worldwide activities AstraZeneca global spotlight diverse range issues affect concern stakeholders society including climate change know effective management issues critical maintaining trust confidence AstraZeneca company committed delivering business success responsibly systems place identifying challenges opportunities associated corporate responsibility frameworks clear accountabilities managing consistently appropriately line strategic objectives continue use stakeholder engagement external benchmarking touch external environment changing demands sustainable development combine internal risk assessment identify priorities inform strategy development action planning Knowledge Management function provides legislative current awareness programme make sure remain touch emerging regulatory risks opportunities example quarterly bulletin process appended information Ensuring compliance critical good corporate governance work Compliance Audit functions dedicated ensuring deliver commitments continue appropriate effective risk governance compliance frameworks place Seven AstraZeneca facilities held CO2 emission permits phase EU Emissions Trading Scheme (ETS) total sites received allocations 226 thousand tonnes years phase EU ETS result internal abatement efforts able trade surplus allocation phase generated revenue reinvested energy efficiency inside AZ received lower allocations second phase EU ETS 2008 2012 allowing divestment 2007 seven sites affected existing planned emission abatement activities mean emissions exceed allocations anticipate net purchaser credits meet compliance commitments EUETS Phase II foresee existing reasonably predictable regulatory frameworks EU Energy Performance Buildings Directive UK Carbon Reduction Commitment having significant financial compliance impacts organization far greater importance delivering proactive action mitigate climate change emissions role contributing societal response adaptation especially area healthcare provision changing disease patterns risks described changed signficantly months continue track developments UNFCCC G8 anticipate action EU national government levels implement outcome Bali Roadmap process establish Post Kyoto international control framework

 
information

Download attachment
 
2 Physical Risks (CDP6 1(a)(ii))
2 1 company exposed physical risks climate change
We consider our company to be exposed to physical risks. 
processes identifying assessing risks set answer question 1 risks described changed signficantly months Currently AstraZeneca felt little actual impact climate disruption combine global capabilities high quality relationships local markets enable respond quickly effectively changing business needs confident rise adaptive challenges presented climate change employ 65 000 people (51% Europe 32% Americas 17% Asia Africa Australasia) active 100 countries growing presence important emerging markets including China 17 research development centres countries 26 manufacturing sites 18 countries dedicated ensuring deliver secure high quality cost effective supply effective prescription medicines bring benefit patients add value shareholders wider society Climate induced changes disrupt ability operate effectively realise benefits include interruption energy transport infrastructures scarcity water resources disruption key supply chain products services Water resources increasingly limited face climate change facilities representing 12% total water use globally located countries water resources currently classified ‘ highly stressed’ ‘ medium stressed’ UNEP (geodata grid unep ch) recognise responsibility use water wisely protecting ability operate effectively areas China example active programme minimize water use place including efficient use cooling water Similarly India R& D site effluent treatment plant process water recycled 90% used purposes maintaining landscaped garden Australian manufacturing site joined national “ Drop Counts” water minimization programme Mexico consumption fresh water subsequent wastewater emissions reduced use reverse osmosis Water does meet quality standards used non process non potable purposes

 
information

 
3 Risks (CDP6 1(a)(iii))
3 1 company exposed risks result climate change
We consider our company to be exposed to other risks. 
processes identifying assessing risks set answer question 1 risks described changed signficantly months AstraZeneca exposed generic risks businesses potential power supply instabilities variable access renewable energy sources disruption interruption key supply chains Climate change bring impacts specific relevance AstraZeneca pharmaceutical industry increasingly recognised climate change just environmental issue affects health livelihood millions people relationship climate change health extremely complex indirect direct impacts peoples’ health evaluated evidence suggests rising temperatures result increases vector water food borne diseases cardio respiratory problems extreme weather events floods storms droughts causing malnutrition social disruption death Disrupted weather systems result drought areas flooding leading malnutrition result reduced agricultural productivity supply chain failures Flooding impact sanitation clean water supplies contaminating water leading array gastrointestinal infections increasing incidence water borne diseases malaria cholera affect power supplies infrastructure hampering provision healthcare delaying disaster relief significantly hindering emergency response Climate change affect areas world vulnerability climate change strongly regionally differentiated developed countries tropical subtropical areas susceptible adverse impact dependence natural resources limited ability adapt changing environment poor disproportionably affected resources likely bear greatest burden putting pressure achieving Millennium Development Goals 2015 killer diseases highly sensitive climatic conditions spread conditions change instance recently outbreaks malaria highland regions Kenya steps mitigate situation addressing causes climate change reducing impact environment Individuals communities governments responsibility make necessary policy behaviour changes AstraZeneca takes responsibility seriously sustainability explicitly integrated AstraZeneca’ s Corporate Responsibility Priority Action Plan Key performance indicators targets established climate change waste Furthermore business fighting disease provide medicines help patients physicians combat significant threats life health AstraZeneca consider value medicines patients society heart corporate responsibility effort Innovation drives progress society case pharmaceuticals innovative medicines bring benefits patients improving health quality life millions people worldwide create wealth contribute economic development communities serve

 
information

 
4 Regulatory Opportunities (CDP6 1(b)(i))
4 1 regulatory requirements climate change present opportunities company
Regulatory requirements present opportunities for my company. 
processes identifying assessing risks opportunities associated climate change set answer question 1 opportunities described changed signficantly months opportunities specific AstraZeneca identified related regulatory changes support use regulatory mechanisms provide effective framework encourage industry participate invention development use low carbon adaptive solutions example appropriate coherent financial tax trade policies include use market based mechanisms help internalise true cost carbon promote development use low carbon technologies long term solutions Mandatory disclosure requirements useful role increasing number consistency climate related reports published private public sector organisations urge climate change regulatory framework consistent Millenium Development Goals particular need 1 secure affordable sustainable energy supplies advance social economic goals 2 improved access safe water sanitation furthering health wellbeing Initiatives REACH inclusion environmental risk information Swedish Doctors Prescribing guide (fass se) provide potential models future mechanisms advocating improved transparency environmental performance pharmaceutical products Currently opportunities largely represented potential reduce operating costs environmental impacts enhance reputation stakeholders

 
information

 
5 Physical Opportunities (CDP6 1(b)(ii))
5 1 physical changes resulting climate change present opportunities company
Physical changes do not present opportunities for my company. 
processes identifying assessing risks opportunities associated climate change set answer question 1 opportunities described changed signficantly months specific opportunities identified related physical changes opportunities largely represented potential reduce operating costs environmental impacts enhance stakeholder acceptability organization

 
information

 
6 Opportunities (CDP6 1(b)(iii))
6 1 Does climate change present opportunities company
Climate change presents other opportunities for my company. 
Climate change aspect sustainability sufficient deal climate risks opportunities isolation climate issue framed wider context including issues material efficiency availability safe clean water reducing travel transport supply chain accountability healthcare innovation infrastructure improvement Furthermore business fighting disease Alongside medical societal drivers posed increasing life expectancy population growth diseases currently adequate treatments climate change impact disease patterns healthcare needs work relates emerging needs including developing respiratory therapy product portfolio effective treatment asthma chronic obstructive pulmonary disease (COPD) committing resource discovery development new treatments tuberculosis (TB) working NGOs partners AMREF AXIOS VSO British Red Cross help local communities developing world strengthen healthcare capabilities examples given illustrate AstraZeneca positioned respond changing healthcare needs society business strategy centres strengthening research development pipeline new medicines whilst working improve efficiency development processes ensure medicines patients quickly Underpinning strategy continue promote culture responsibility accountability aspects business activity make interaction count ensuring AstraZeneca continues welcomed trusted member society

 
information

 
Greenhouse Gas (GHG) Emissions Accounting, Emissions Intensity, Energy and Trading
7 Reporting Year (CDP6 Q2(a)(ii))
Information respond section “ Greenhouse Gas Protocol Corporate Accounting Reporting Standard (Revised Edition)” developed World Resources Institute World Business Council Sustainable Development (“ GHG Protocol” ) http //www ghgprotocol org/ ISO 14064 1 compatible GHG Protocol number regional/national programme protocols information http //www ghgprotocol org/ use guidance button provide CDP responses questions 7 8 9 10 1 10 2 11 1 11 2 years prior current reporting year time answered CDP information request work backwards current reporting year enter data oldest reporting period Questions 10 1 10 2 11 1 11 2 subsequent webpages dates answer question 7 carried forwards automatically populate webpages
7 1 state start date end date year reporting GHG emissions
Start date 01 January 2008End date 31 December 2008

 
8 Reporting Boundary (CDP6 Q2(a)(i)) 8 1 indicate category describes company entities group Scope 1 Scope 2 GHG emissions reported
Companies over which financial control is exercised – per consolidated audited Financial Statements. 

 
8 2 state parts business sources GHG emissions excluded reporting boundary
general boundary reporting companies financial control exercised consolidated audited Financial Statements facilities related healthcare business included exception MedImmune including Cambridge Antibody Technology acquired AstraZeneca 2007 Data KuDOS Arrow Therapeutics acquired 2007 incoprorated report continue work effectively align programmes strategic level MedImmune time performance included data 2008 turnover new MedImmune group members $1334 million compared $31601 million turnover group indicates data presented covers approx 95 8% group turnover Businesses divested Company included date divestment

 
9 Methodology (CDP6 Q2(a)(iii)) 9 1 process used company calculate Scope 1 Scope 2 GHG emissions including standard protocol methodology used collect activity data calculate Scope 1 Scope 2 GHG emissions provide answer text box addition description relevant select methodology list published methodologies aid automated analysis data
use internally developed collecting assessing Safety Health Environment performance data majority data needed compile GhG inventory collected accuracy assured global reporting Safety health environmental data received parts AstraZeneca quarterly AZSHE department facility required report performance set criteria defined mandatory global reporting procedure Currently 149 submissions data received 114 locations 65 countries Regular review data carried ensure accuracy consistency lead slight changes statistics produced previous years statistics quoted response generated revised data treatment baseline target reported data accordance guidance held Greenhouse Gas Protocol (WRI/WBCSD 2004 Revised Edition Chapter 5 – Tracking Emissions Time Chapter 7 – Managing Inventory Quality) GRI Sustainability Reporting Guidelines provide advice issue global procedure calculating grenhouse gas contributions appended information

 
Select methodologies
The Greenhouse Gas Protocol: A Corporate Accounting and Reporting Standard (Revised Edition)


 
provide

 
9 2 Details assumptions
attached global greenhouse gas proceudre note assumptions

 
9 3 names links calculation tools used

 
Select calculation tools

 
9 4 global warming potentials applied origin
attached greenhouse gas procedure note GWPs applied source references

 
9 5 emission factors applied origin
attached spreadsheet emission factors applied fuels electricity grid emission factors waste incineration source references

 
information

Download attachment
Download attachment
 
10 Scope 1 Direct GHG Emissions (CDP6 Q2(b)(i))
Instructions question 10 question 11 (following page)When providing answers questions 10 11 deduct offset credits Renewable Energy Certificates net estimated avoided emissions export renewable energy carbon sequestration (including enhanced oil recovery) use goods services Opportunities provide details activities reduce avoid emissions provided information request Carbon dioxide emissions biologically sequestered carbon e g carbon dioxide burning biomass/biofuels reported separately emissions Scopes 1 2 3 relevant report emissions question 15 include nitrous oxide methane emissions biomass/biofuel combustion emissions scopes
answer following questions using Table 1 provide 10 1 Total gross global Scope 1 GHG emissions metric tonnes CO2 ePlease break total gross global Scope 1 emissions 10 2 Country regionPlease provide CDP responses questions 10 1 10 2 years prior current reporting year time answered CDP information request work backwards current reporting year enter data oldest reporting period Table 1 (below) table 5 (Q11 1 11 2) automatically populated dates answer 7 1 Electric utilities report emissions country/region using table question EU3 Table 1 use numbers Use “ Other” option drop menu enter region
Reporting year Q7.1 Start date 01/01/2008
Reporting year Q7.1 End date 31/12/2008
10.1 Total gross global Scope 1 GHG
emissions in metric tonnes CO2-e
421200

10.2 Gross Scope 1 emissions in metric tonnes CO2-e by country or region

Sweden 13200
United Kingdom 148300
USA 41800
Asia 3500
Central & South America 19500
Europe excluding Sweden & UK 13500
Rest World 6800

 
answer question 10 1 automatically carried forward tables 2 3 add country region answer 10 2 press “ Save” end page tick box total gross global Scope 1 figure (Q10 1) includes emissions transferred outside reporting boundary (as given answer 8 1) report transfers 13 5

 
facilitate better understanding business break total global Scope 1 emissions 10 3 Business divisionand/or10 4 Facility10 3 Business division (only data current reporting year requested)Table 2 use numbers
Business Divisions - Enter names below
Scope 1 Metric tonnes CO2-e
Total gross global Scope 1 GHG emissions in metric tonnes CO2-e - answer to question Q10.1 421200

 
10 4 Facility (only data current reporting year requested)Table 3 use numbers
Facilities - Enter names below
Scope 1 Metric tonnes CO2-e
Total gross global Scope 1 GHG emissions in metric tonnes CO2-e - answer to question Q10.1 421200

 
10 5 break total global Scope 1 GHG emissions metric tonnes gas metric tonnes CO2 e GHG type (Only data current reporting year requested )Table 4 use numbers
Scope 1 GHG Type
Unit
Quantity
CO2 Metric tonnes 401850
CH4 Metric tonnes
CH4 Metric tonnes CO2-e
N2O Metric tonnes
N2O Metric tonnes CO2-e
HFCs Metric tonnes
HFCs Metric tonnes CO2-e 19350
PFCs Metric tonnes
PFCs Metric tonnes CO2-e
SF6 Metric tonnes
SF6 Metric tonnes CO2-e

 
10 6 provided information Scope 1 emissions response questions explain reasons plans collecting Scope 1 GHG emissions information future

 
information
Country region specific Scope data include facility energy related direct emissions facility based GHG emissions mainly refrigeration plant process emissions VOCs F gases car fleet emissions included corporate total Corporate Scope total 421200 tonnes CO2 eq 246600 tonnes facility energy use 25600 tonnes (including 19350 tonnes CO2 eq HFC emissions) process related 149000 car fleet

 
11 Scope 2 Indirect GHG Emissions (CDP6 Q2(b)(i))
Important note emission factors zero low carbon electricity purchased emissions factor use calculating Scope 2 emissions depends electricity purchase counted calculating grid average emissions factor – supplier Electricity counted calculating grid average emissions factor electricity sourced grid electricity counted calculating grid average emissions factor Scope 2 emissions calculated using grid average emissions factor company purchases electricity zero low carbon electricity tariff Electricity counted calculating grid average emissions factor zero low carbon electricity sourced grid transmitted company electricity counted calculating grid average emissions factor specific method generation used provided certificates quantifying GHG related environmental benefits claimed electricity sold passed separately electricity purchased Click instructions previous page answering question 11
answer following questions using Table 5 provide 11 1 Total gross global Scope 2 GHG emissions metric tonnes CO2 e break total gross global Scope 2 emissions 11 2 Country regionPlease provide CDP responses questions 11 1 11 2 years prior current reporting year time answered CDP information request work backwards current reporting year enter data oldest reporting period Table 5 automatically populated dates gave answer 7 1 Table 5 use numbers Use “ Other” option drop menu enter region
Reporting year Q7.1 Start date 01/01/2008
Reporting year Q7.1 End date 31/12/2008
11.1 Total gross global Scope 2 GHG
emissions in metric tonnes CO2-e
277140

11.2 Gross Scope 2 emissions in metric tonnes CO2-e by country or region

Sweden 21600
United Kingdom 62100
USA 83800
Asia 31500
Central & South America 18000
Europe excluding Sweden UK 40000
Rest World 20000

 
answer 11 1 automatically carried forward tables 6 7 add country region answer 11 2 press “ Save” end page facilitate better understanding business break total global Scope 2 emissions 11 3 Business divisionand/or11 4 Facility11 3 Business division (only data current reporting year requested)Table 6 use numbers
Business Divisions - Enter names below
Scope 2 Metric tonnes CO2-e
Total gross global Scope 2 GHG emissions in metric tonnes CO2-e - answer to question Q11.1 277140

 
11 4 Facility (only data current reporting year requested)Table 7 use numbers
Facilities - Enter names below
Scope 2 Metric tonnes CO2-e
Total gross global Scope 2 GHG emissions in metric tonnes CO2-e - answer to question Q11.1 277140

 
11 5 provided information Scope 2 emissions response questions explain reasons plans collecting Scope 2 GHG emissions information future

 
information

 
12 Contractual Arrangements Supporting Particular Types Electricity Generation (CDP6 Q2(b)(i) Guidance)
12 1 consider grid average factor used report Scope 2 emissions question 11 does reflect contractual arrangements electricity suppliers (for example purchase electricity using zero low carbon electricity tariff) calculate report contractual Scope 2 figure response question showing origin alternative emission factor information tariff

 
12 2 retire certificates (eg Renewable Energy Certificates) associated zero low carbon electricity provide details

 
information

 
13 Scope 3 Indirect GHG Emissions (CDP6 Q2(c))
following categories main sources emissions Report emissions metric tonnes CO2 e state methodology assumptions calculation tools databases emission factors (including sources) global warming potentials (including sources) used calculating emissions Notes question 13When providing answers question 13 deduct offset credits Renewable Energy Certificates net estimated avoided emissions export renewable energy carbon sequestration (including enhanced oil recovery) use goods services Opportunities provide details activities reduce avoid emissions provided information request Carbon dioxide emissions biologically sequestered carbon e g carbon dioxide burning biomass/biofuels reported separately emissions Scopes 1 2 3 relevant report emissions question 15 include nitrous oxide methane emissions biomass/biofuel combustion emissions scopes
13 1 Employee business travelDescribe main sources emissions
Business air travel Note business road travel owned leased cars included Scope data Question 10

 
Emissions metric tonnes CO2 e
42900

 
State methodology assumptions calculation tools databases emission factors (including sources) global warming potentials (including sources) used calculating emissions
Air travel data provided corporate travel agency covering 100 routes used year AZ employees Air mile data mutliplied relevant emission factors 0 177 kg/mile (long haul) 0 2028 (medium haul) 0 2897 (short haul) total gained multiplied coverage factor 65% account data availability 100 routes

 
13 2 External distribution/logisticsDescribe main sources emissions
Air road distribution intermediates AZ sites secondary (contract) manufacturers final product distribution wholesalers

 
Emissions metric tonnes CO2 e
Goods air transport 93200 Goods road transport 50200

 
State methodology assumptions calculation tools databases emission factors (including sources) global warming potentials (including sources) used calculating emissions
Data sourced frieght & logistics survey

 
13 3 Use/disposal company’ s products servicesFor auto manufacture auto component companies – refer additional questions sectors completing question 13 3 main sources emissions
Principle source emissions use phase product life cycle release propellant inhaler devices treatment respiratory diseases asthma chronic obstructive pulmonary diesease devices generally use HFC propellant

 
Emissions metric tonnes CO2 e
289500

 
State methodology assumptions calculation tools databases emission factors (including sources) global warming potentials (including sources) used calculating emissions
assumed total charged volume propellant device discharged atmosphere use disposal GWP factors propellants sourced IPCC (please greenhouse gas procedure note attached question 9 methodological emission factor detail)

 
13 4 Company supply chainDescribe main sources emissions
principle sources supply chain emissions tracked waste incineration party manufacture key intermediates bulk drug products

 
Emissions metric tonnes CO2 e
Waste incineration 48500Third party manufacture 71400

 
State methodology assumptions calculation tools databases emission factors (including sources) global warming potentials (including sources) used calculating emissions
Emissions waste incineration calculated quarterly performance survey sites emission factors derived IPCC (please greenhouse gas procedure note attached question 9 methodological emission factor detail) party manufacturers key AZ product intermediates final bulk drug materials identified receive request performance data disclosure annually covering energy waste parameters require facilities energy consumption waste data received calculation methodology emission factors applied sites generate comparable emission data (please greenhouse gas procedure note emission factor spreadsheet attached question 9 methodological emission factor detail) note party performance data survey operates step internal quarterly annual reporting cycle data provided relates financial year 2007

 
13 5 OtherIf reporting emissions fall categories categorise transferred emissions non transferred emissions (please guidance explanation terms) report transfers input fields non transfers input fields TransfersDescribe main sources emissions

 
TransfersReport emissions metric tonnes CO2 e

 
TransfersState methodology assumptions calculation tools databases emission factors (including sources) global warming potentials (including sources) used calculating emissions

 
Non transfersDescribe main sources emissions

 
Non transfersReport emissions metric tonnes CO2 e

 
Non transfersState methodology assumptions calculation tools databases emission factors (including sources) global warming potentials (including sources) used calculating emissions

 
13 6 provided information categories Scope 3 GHG emissions response questions explain reasons plans collecting Scope 3 indirect emissions information future

 
information

 
14 Emissions Avoided Use Goods Services (New CDP 2009)
14 1 goods and/or services enable GHG emissions avoided party provide details including estimated avoided emissions anticipated timescale emissions avoided methodology assumptions emission factors (including sources) global warming potentials (including sources) used estimations
1987 introduced Turbuhaler dry powder inhaler replaced 83% existing propellant driven devices (pMDIs) inhaled therapies respiratory diseases asthma chronic obstructive pulmonary disease whilst meeting medical needs majority patients Following exhaustive search years development introduced alternative propellants inhalation devices patients Turbuhaler unsuitable new hydrofluoroalkane (HFA) propellant gases ozone depletion potential global warming potential CFCs replace gases impact climate change international consensus safer alternative patients dry powder Turbuhaler device available emissions treating patient numbers pMDIs approx 1 4 million tonnes CO2 eq higher consider transition CFC HFC propellants pMDI device claimed provide avoided emission benefits requirement CFC phase Montreal Protocol

 
information

 
15 Carbon Dioxide Emissions Biologically Sequestered Carbon (New CDP 2009)
example carbon dioxide burning biomass/biofuels

 
15 1 provide total global carbon dioxide emissions metric tonnes CO2 biologically sequestered carbon Emissions metric tonnes CO2 use numbers
0

 
information

 
16 Emissions Intensity (CDP6 Q3(b))
16 1 supply financial emissions intensity measurement reporting year combined Scope 1 2 emissions measurement
Data provided expressed emissions relative revenue company excluding revenue members MedImmune group answer question 8 explanation exclusion

 
16 1 1 units example units metric tonnes CO2 e million Yen turnover metric tonnes CO2 e US$ profit metric tonnes CO2 e thousand Euros turnover
metric tonnes CO2 e US$ revenue

 
16 1 2 resulting figure Use decimal point necessary use “ ” “ ” e write 15 6 15 6
18

 
16 2 supply activity related intensity measurement reporting year combined Scope 1 2 emissions measurement
appropriate indicator emission intensity business revenue value measured US$ product small drug blister pack weighs information leaflet let packaging mass outputs unhelpful purpose indicator impact/benefit ratios

 
16 2 1 units e g metric tonnes CO2 e metric tonne output service sector businesses unit service provided

 
16 2 2 resulting figure Use decimal point necessary use “ ” “ ” e write 15 6 15 6

 
information

 
17 Emissions History (CDP6 Q2(f))
17 1 emissions reporting year vary significantly compared previous years
Yes 
Contributions overall decrease come decreasing emissions major categories direct energy use business road travel accordance reduction commitment expressed 2006 2010 improvement objective

 
answer 17 1 Yes 17 1 1 Estimate percentage emissions vary compared previous reporting year box accept numerical answers containing decimal point use " " " " e write 10 6 10 6
5 %

 
emissions increased decreased
Decreased 

 
information

 
18 External Verification/Assurance (CDP6 Q2(d))
18 1 information reported response questions 10 – 15 externally verified/assured
Yes, it has been externally verified/assured in whole or in part.(Please continue with questions 18.2 to 18.5) 

 
aid automated analysis responses select responses tick boxes use text box provided tick boxes menu options appropriate

 
18 2 State scope/boundary emissions included verification/assurance exercise
Scope 1 Q10.1
Scope 2 Q11.1
Scope 3 external distribution/logistics Q13.2
Scope 3 use/disposal of company’s products inc services Q13.3
Scope 3 Company supply chain Q13.4


 
use text box scope/boundary emissions included verification/assurance exercise tick box menu options applicable

 
18 3 State level assurance (eg reasonable limited) given
Bureau Veritas' assurance work planned carried provide reasonable absolute assurance

 
18 4 Provide copy verification/assurance statement attach copy/copies

 
18 5 Specify standard information verified/assured
assurance process conducted line requirements AA1000 Assurance Standard (AS 2003) scope work included review AstraZeneca’ s performance G3 Global Reporting Initiative (GRI) B+ application level

 
18 6 information provided response questions 10 15 verified state plans GHG emissions accounting information externally verified/assured future

 
information
Q18 4 external assurance statement http //www astrazeneca com/responsibility/reporting performance/external assurance statement itemId=4821545& nav=yes

 
19 Data Accuracy (CDP6 Q2(e) – New wording CDP 2009)
19 1 main sources uncertainty data gathering handling calculations e g data gaps assumptions extrapolation metering/measurement inaccuracies gather emissions data select emissions data gathered proceed question 20
Emission data is gathered. 
data used generate greenhouse gas inventory obtained metered and/or invoiced sources e g fuel use electricity import waste disposal incineration Oue internal safety health environmental reporting requires individual sites maintain data collection systems paramaters business road mileage Similarly internal financial control reporting systems generate inhaler product device volumes used calculation product emissions Suppliers generate provide data calculation business air travel freight & logistic activity emissions Emission factors introduce bias inaccuracies aim select use robust universally acknowledged sources disposal sources specific data accuracy robustness levels believed robust data extrapolated generic surrogate sources

 
19 2 uncertainties affect accuracy reported data percentage terms estimated standard deviation
calculated percent bias introduced sources data uncertainty

 
19 3 Does company report GHG emissions mandatory voluntary scheme (other CDP) requires accuracy assessment
Yes (Please answer the following questions - 19.3.1, 19.3.2). 

 
19 3 1 provide scheme
EU emissions trading scheme 

 
19 3 2 provide accuracy assessment GHG emissions reported scheme report delivered

 
information

 
20 Energy Fuel Requirements Costs (New CDP 2009)
provide following information reporting year Cost purchased energy
20 1 total cost electricity heat steam cooling purchased company

 
Select currency

 
20 1 1 break costs individual energy type Table 8 “ Cost” column accept text use numbers
Energy type
Cost
Currency
 Electricity
 Heat
 Steam
 Cooling

 
Cost purchased fuel20 2 total cost fuel purchased company mobile stationary combustion

 
Select currency

 
20 2 1 breakdown costs individual fuel type Table 9 cost column accept text use numbers
Mobile combustion fuels
Cost
Currency

 
Stationary combustion fuels
Cost
Currency

 
Energy fuel inputsThe following questions designed establish company’ s requirements energy fuel (inputs) note MWh preferred unit answers helps comparability analysis usually associated electricity equally used represent energy content fuels (see CDP2009 Reporting Guidance information conversions MWh) Purchased energy input20 3 company’ s total consumption purchased energy MWh use numbers
1110000 MWh

 
Purchased self produced fuel input20 4 company’ s total consumption MWh fuels stationary combustion includes purchased fuels biomass self produced fuels relevant use numbers
1190000 MWh

 
answering question used Higher Heating Values (also known Gross Calorific Values) Lower Heating Values (also known Net Calorific Values) state used calculating answers
Net Calorific Value

 
20 4 1 break total consumption fuels reported answer question 20 4 individual fuel type MWh Table 10 use numbers
Stationary combustion fuels
MWh
Natural gas 1090000
Gas oil distillate fuel oils Nos 1 2 4 64000
Heavy fuel oils Residual fuel oils Nos 5 & 6 15100
sources principally waste solvent (secondary liquid fuel) 14700

 
Energy outputIn question ask information energy MWh generated company fuel uses Comparing energy contained fuel combustion (question 20 4) energy available use combustion indication efficiency combustion processes taking industry sector account 20 5 total energy generated MWh fuels reported question 20 4 use numbers

 
20 6 total MWh renewable energy excluding biomass self generated company use numbers

 
Energy exportsThis question companies export energy surplus requirements example company use electricity combined heat power plant export heat organisation 20 7 percentage energy reported response question 20 5 exported/sold company grid parties use numbers
2 %

 
20 8 percentage renewable energy reported response question 20 6 exported/sold company grid parties use numbers

 
information
Questions 20 1 20 2 collate individual energy source cost data corporate level total AZ expenditure energy sources (scope II) 2008 US$146million Questions 20 5 & 20 6 track energy output majority energy consumed site processes exception CHP plant located Macclesfield UK facility does export surplus electricity UK distribution grid reported Q20 7 Note percentage figure given Q20 7 proportional group direct energy input energy output figure

 
21 EU Emissions Trading Scheme (CDP6 Q2(g)(i) – New wording CDP 2009)
Electric utilities report allowances emissions using table question EU5 21 1 Does company operate ownership facilities covered EU Emissions Trading Scheme (EU ETS)
Yes (Please answer the following questions - 21.2 to 21.4) 

 
details 21 2 allowances allocated free year Phase II facilities operate (Even wholly facilities number allowances) Table 11 use numbers
2008
2009
2010
2011
2012
Free allowances metric tonnes CO2 199300 199300 199300 199300 199300

 
21 3 total allowances purchased national auctioning processes period 1 January 2008 31 December 2008 facilities operate (Even wholly facilities total allowances purchased auctions facilities period) Total allowances purchased auction
0

 
21 4 total CO2 emissions 1 January 2008 31 December 2008 facilities operate (Even wholly facilities total emissions period )Total emissions metric tonnes
147900

 
information

 
22 Emissions Trading (CDP6 Q2(g)(ii) New wording CDP 2009)
Electric utilities read EU6 answering questions
22 1 provide details emissions trading schemes EU ETS company participates likely participate years
We participate or anticipate participating in trading schemes other than the EU ETS in the next two years. 
major UK located sites voluntary participants Climate Change Agreement Chemical Industries Association anticipate obliged enter UK Government Carbon Reduction Commitment January 2010

 
22 2 overall strategy complying schemes required elected participate including EU ETS
managing emissions sites inside EU Emissions Trading Scheme net purchaser allowances second phase scheme EUETS Phase able sell small net surplus allocation proceeds reinvested energy efficiency facilities intend engage strategic permit trading income generating activity intend manage commitments trading positions similarly UK CRC scheme mandatory commitments trading schemes intend use CDM/JI voluntary emission reduction credits support strategy reduce emissions successfully operated pilot trial UK business engage party offset project developer order explore practical application offset credit procurement help refine strategic approach offset New Zealand sales force recently swapped fleet vehicles smaller efficient diesel powered cars visible demonstration environmental impact initiative worked local council plant equivalent number trees offset emissions inside newly created community forest certificates created sold activity plans stage use offset make company carbon neutral believe work internal drive reduce emissions far possible

 
information

 
22 Carbon credits
22 3 purchased project based carbon credits
No. (Please go to question 22.5) 

 
indicate credits meet following commitments

 
22 4 Provide details including type unit volume vintage purchased standard/scheme credits verified issued retired (where applicable)

 
22 5 involved origination project based carbon credits
No. (Please go to question 22.7) 

 
22 6 provide details including • role project(s) • locations technologies involved • standard/scheme projects being/have developed • emissions reductions validated verified • annual volumes generated/projected carbon credits • Retirement method used compliance offsetting

 
22 7 involved trading allowances EU ETS and/or project based carbon credits separate business activity direct support business activity investment fund management provision offsetting services
No. (Please go to question 23) 

 
22 8 provide details role performed

 
information

 
Performance
23 Reduction plans & goals (CDP6 Q3(a))
23 1 Does company GHG emissions and/or energy reduction plan place
Yes. (Please go to question 23.3) 

 
23 2 explain aid automated analysis responses select response options using text box just use text box provided options appropriate

 
menu options appropriate answer question using text box

 
Goal setting23 3 emissions and/or energy reduction target(s)
Yes. (Please answer the following questions) 

 
23 4 baseline year target(s)
reference point reduction objectives average emissions 2001 2002

 
23 5 emissions and/or energy reduction target(s)
2006 – 2010 climate change target aims ensure absolute emissions 2010 greater start decade 55% 1990 committed achieving 2010 target compromising ability provide new inhalation therapies bring benefit patients particular new asthma therapy Symbicort rapihaler launched USA 2007 means emissions products rise period 2010 climate change objectives include secondary target produce 2010 absolute reduction 12% global warming emissions sources inhalers compared 2005

 
23 6 sources activities target(s) applies
GhG protocol Scope II III source activities included targeted improvements

 
23 7 period/timescale does target(s) extend
2006 2010

 
information

 
23 GHG emissions energy reduction activities
23 8 activities undertaking planning undertake reduce emissions/energy use
continue drive implementation initiatives programmes focused managing carbon footprint key areas business activity example recognising significant global warming emissions business road travel sales marketing activities continue invest advanced driver training improve safety efficiency associated road travel increasingly using range hybrid alternative fuel vehicles 2008 worked fleet management leasing suppliers introduce fleet reporting track CO2 emissions new existing fleet (where data available) end 2008 data available 18 European markets 7500 cars gave average CO2 emission figure 163g/km Fleet programs starting 2009 plan introduce CO2 caps new car acquisitions major European markets example marketing company Italy set 160g/km CO2 cap January 2009 marketing company Belgium 175g/km maximum place eliminated use ozone depleting substances protection systems adopted policy replace small amounts remaining use refrigeration sites eliminate uses soon feasible minimum timeframe consistent legislative requirements AstraZeneca does use large energy relative size recognise importance implementing programmes maximise efficiency minimise emissions Progress corporate level building proportion renewable energy energy procurement contracts considering energy impact capital programmes addition sites world pursuing energy efficiency projects significant improvements example sites recently awarded Energy Star label Gold Certification Leadership Environmental Energy Design (LEED) Green Building Rating SystemTM work Wilmington location achieve Energy Star label joint program EPA Department Energy Wilmington Energy Team developed comprehensive plan reduce energy use including improvements heating cooling systems identifying areas heat loss sealing air leaks reducing lighting result initiatives scored 25% facilities country energy performance earned Energy Star label UK continue source electricity headquarters building London environmental science facility Devon large research site Leicestershire guaranteed CO2 free renewable resources 38 kte CO2 avoided sites world using renewable power 2008 areas driving improvement include Implementation green technology principles process design Exploring potential investment low carbon renewable energy options sites investment greener energy supply external power suppliers Implementation energy conservation programmes particularly related fume cupboards laboratories goods transport selected logistic road haulage companies partner main distribution routes prioritise selection partners basis safety health environment quality management efficiency air road fleets taken consideration Alongside continuously seek use external opportunities share learning foster best practice 2008 AstraZeneca conjunction European road freight logistics provider recognised European Outsourcing Awards success new initiative load product vehicles product companies minimising vacant space significantly reducing costs environmental impact

 
information

 
23 Goal evaluation
23 9 benchmarks key performance indicators use assess progress emissions/energy reduction goals set
perform benchmarking climate change management approach goals performance pharmaceutical industry peers using publicly available information company websites CDP disclosure data particiapte cross industry benchmarking best practice sharing organisation Pharmaceutical Environment Network obtain benchmark information participation FTSE4Good Dow Jones Sustainability Indices focused stakeholder engagement processes including investors academics NGOs peer companies CR specialists

 
information

 
23 Goal achievement
23 10 emissions reductions energy savings associated cost savings achieved date result plan and/or activities described state methodology data sources used calculating reductions savings
total greenhouse gas emissions 2008 1 2million tonnes CO2 eq compared 2001 2002 reference emissions 1 7 million tonnes CO2 eq Underlying emissions excluding inhaler products 0 93 million tonnes CO2 eq 2008 equaling base year (2005) emissions representing 20% improvement emissions indexed group revenue improvement energy efficiency acheived date equates saving (in 2008) $63million 2008 energy prices given 2005 energy index 102 MWh/$million revenue 2008 index 73 MWh/$million revenue

 
23 11 investment required achieve emissions reductions energy savings targets carry activities listed response question 23 8 period investment Table 13 “ Investment number” column accept text use numbers
Emission reduction target/energy saving target or activity
Investment number
Investment currency
Timescale

 
information
Question 23 11 track separately investments meet environmental objectives investment projects expected stand merits individual business cases basis expect revenue savings improved energy efficiency outweigh investment costs example higher efficiency low emission vehicles lower operating fuel costs tend retain higher resale values end working life Similarly new construction refurbishment existing assets delivered building sustainability features embedded small incremental capital cost offset lower lifetime costs

 
23 Goal planning & investment
Electric utilities read table question EU3 giving details forecasted emissions
23 12 investment required achieve future targets set reduction plan carry activities listed response question 23 8 period expect payback investment Table 14 “ Number” column accept text use numbers
Plan or action
Investment number
Investment currency
Payback

 
23 13 estimate company’ s future Scope 1 Scope 2 emissions years main territories regions operate provide qualitative explanation expected changes impact future GHG emissions possible use table 15 structure answer question alternatively use text box

 
Scope 1 forecasted emissions Table 15 following units
tonnes CO2 eq

 
Scope 2 forecasted emissions Table 15 following units
tonnes CO2 eq

 
Table 15 “ Scope” columns accept text use numbers Type territory region giving data press “ Add Territory/Region” giving global figure instead separate figures regions territories write “ global” box labelled “ Enter territory region” Click sample table
Future reporting years:
End date for year end DD/MM/YYYY 31/12/2009 31/12/2010
Emission forecasts
Scope 1
Scope 2
Scope 1
Scope 2
Scope 1
Scope 2
Scope 1
Scope 2
Scope 1
Scope 2
Global 404100 266900 386600 257100

 
23 14 estimate company’ s future energy use years main territories regions operate provide qualitative explanation expected changes impact future GHG emissions possible use table 16 structure answer question alternatively use text box

 
Table 16 use numbers Type territory region giving data description data giving e g electricity consumption press “ Add Row” giving global figure instead separate figures regions territories use word “ global” table accept different types units e g units volume mass Click sample table
Future reporting years:
End date for year end DD/MM/YYYY
31/12/2009 31/12/2010
Energy use estimates for territory/region
Number
Units
Number
Units
Number
Units
Number
Units
Number
Units
Global 2220 GWh 2140 GWh

 
23 15 explain methodology used estimations assumptions
projected future emissions 2010 order predict attainment 2006 2010 emissions targets projections use actual figures previous years emissions establish intensity trends incorporate actuarial estimates future corporate sales growth predict base case emissions Overlain estimates information sales forecasts established planned introductions new inhalation products projected attainment emission control activities analysis indicates able exit decade emitting greenhouse gases did start decade 55% did 1990

 
information
Question 23 12 track separately investments meet environmental objectives investment projects expected stand merits individual business cases basis expect revenue savings improved energy efficiency outweigh investment costs example higher efficiency low emission vehicles lower operating fuel costs tend retain higher resale values end working life Similarly new construction refurbishment existing assets delivered building sustainability features embedded small incremental capital cost offset lower lifetime costs

 
24 Planning (CDP6 Q3(c))
24 1 factor cost future emissions capital expenditures impact estimated costs investment decisions
direct costs emissions small impact overall financial position capital investments account sustainability considerations including indirect operational costs utility costs significant adjustments capital programme result emissions costs

 
information

 
Governance
25 Responsibility (CDP6 Q4(a))
25 1 Does Board Committee executive body overall responsibility climate change
Yes. (Please answer question 25.3 and 25.4) 

 
25 2 state overall responsibility climate change managed indicate highest level company responsibility climate change
AstraZeneca Board owns CR strategy setting direction management including climate change ensuring Policy established integral business activities Non Executive Director Professor Dame Nancy Rothwell responsible overseeing implementation strategy Company Chief Executive Officer delegated authority accountable Board Company’ s performance Primary responsibility management cascaded line management Local legal requirements place specific accountabilities Marketing Company Presidents local managers Management designed reinforce confirm accountabilities responsibilities exist line support organisation provided team professionals work locally central organisation Group Policy revised strengthened 2008 wider global policies review new Policy provides business clear framework managing ensuring performance remains strong new Policy framework effective January 2009 new Policy supported set Standards establish minimum performance requirements particular risk areas Standards development publication planned 2009

 
25 3 Board Committee executive body overall responsibility climate change
AstraZeneca Board collective responsibility business strategy related environment including climate change Specific action planning climate change included Corporate Responsibility (CR) strategy Non Executive Director responsibility overseeing implementation strategy Company

 
25 4 mechanism Board executive body reviews company’ s progress status regarding climate change
annual basis Board Senior Executive Team (chaired CEO) formally review provide direction performance strategic initiatives compliance status company’ s objectives climate change framed Corporate Safety Health Environment objectives embedded Corporate Responsibility Priority Action Plan ensures inclusion Senior Executive Team (SET) Business Performance Management (BPM) framework targets deliverables associated high level objectives integrated relevant functional BPM framework appropriately included individual performance objectives Progress objectives levels reviewed year including quarterly review individual business function action plans SET level review SET scorecard AstraZeneca Board

 
information

 
26 Individual Performance (CDP6 Q4(b))
26 1 provide incentives individual management climate change issues including attainment GHG targets
Yes. (Please go to question 26.2)  

 
26 2 incentives linked monetary rewards
Remuneration staff including senior management assessed basis attainment targets Management climate change issues incentivised extent climate change objectives included process environment related CR objectives reflects performance Dow Jones Sustainability Index specific performance measure included Senior Executive Team Business Performance Management (BPM) framework

 
26 3 entitled benefit incentives

 
information

 
27 Communications (CDP6 Q4(c))
27 1 publish information risks opportunities presented company climate change details emissions plans reduce emissions
Yes CDP Annual Report Form 20 F dedicated Responsibility section website

 
indicate following apply provide details and/or link documents copy relevant excerpt 27 2 company’ s Annual Report mainstream filings
Yes 
2008 Annual review available http //www astrazeneca annualreports com/2008/For detailed environmental review including climate change http //www astrazeneca annualreports com/2008/directors_report/environmental_sust/index html

 
27 3 Voluntary communications (other CDP) Corporate Social Responsibility reporting
Yes 
deeper review climate change position performance given Responsibility webpages http //www astrazeneca com/responsibility/climate change/This page accessed directly dedicated link available main corporate home webpage http //www astrazeneca com/

 
information

 
28 Public Policy (CDP6 Q4(d))
28 1 engage policymakers possible responses climate change including taxation regulation carbon trading
Yes 
contribute industry voices links various associations committees membership organisations list avaialbe http //www astrazeneca com/responsibility/community support/memberships charters itemId=4813015& nav=yes

 
information

 
We have upgraded our website login. If you have registered to view CDP responses before December 23, please re-register and we will issue new login details.
  Join the CDP LinkedIn group Follow @cdp on Twitter          Subscribe to receive our monthly newsletter
  Connect with us          Newsletter
   
 
 
  © 2014 CARBON DISCLOSURE PROJECT, Registered Charity no. 1122330.
A company limited by guarantee registered in England no. 05013650